Skip to main content
Press Release

New Castle Resident Indicted on a Charge of Violating Federal Consumer Product Tampering Laws

For Immediate Release
U.S. Attorney's Office, Western District of Pennsylvania

PITTSBURGH, PA - A resident of New Castle, Pennsylvania, has been indicted by a federal grand jury in Pittsburgh on a charge of violating federal consumer product tampering laws, United States Attorney Eric G. Olshan announced today.

The one-count Indictment named Shane Jon-Paul White, age 41, of New Castle, PA, as the sole defendant.

According to the Indictment, between an unknown date and January 26, 2022, White, a former employee of McKesson Corporation, while working at the company’s New Castle Distribution Center, removed oxycodone hydrochloride tablets from bottles of Mallinckrodt-brand oxycodone hydrochloride 30 mg tablets and replaced them with aspirin, Tylenol or Refenesen tablets. After the oxycodone hydrochloride tablets were removed and replaced, the bottles were placed back in inventory at the McKesson distribution center before being transported to pharmacies, including Klein’s Pharmacy in Cuyahoga Falls, Ohio.

The law provides for a maximum total sentence of ten (10) years in prison, a fine of not more than $250,000 or both. Under the Federal Sentencing Guidelines, the actual sentence imposed would be based upon the seriousness of the offense and the prior criminal history, if any, of the defendant.

Assistant United States Attorney Robert S. Cessar is prosecuting this case on behalf of the government.

The U.S. Food and Drug Administration conducted the investigation leading to the Indictment in this case.

An indictment is an accusation. A defendant is presumed innocent unless and until proven guilty.

Updated October 18, 2023

Topics
Opioids
Prescription Drugs